Market Trends of Global Flow Cytometry Industry
Stem Cell Therapy Segment is Expected to Witness a Significant Growth Over the Forecast Period.
Stem cell therapy is expected to make up a significant part of the market in terms of its application. Flow cytometry is used to identify, characterize, and separate stem cells for research and other purposes. This is because it can quickly take quantitative measurements on a single cell in a group of different cells, contributing significantly to the Cell Separation Market and the Cell Analysis Market.
The extensive use of flow cytometry in disease diagnosis and early detection significantly contributes to this segment's large Flow Cytometry Market Share. The growth of the stem cell research market, the use of recombinant DNA technology to make antibodies, and the improvement of tandem flow cytometry technologies are all factors expected to help the major players in the Flow Cytometry Market grow. For instance, according to the National Clinical Trial Registry (NCT), as of April 21, 2021, there were about 320 registered clinical trials across different phases of development related to stem cell therapy in Germany. So, the demand for flow cytometry is likely to grow in the coming years as research into stem cell therapy expands.
Also, in April 2022, The Official Journal of the International Clinical Cytometry Society published an article saying that flow cytometry's ability to quickly process large numbers of cells and use multiple parameters to identify them makes it possible to get enough of even the rarest stem cells for accurate end-point analysis or later use. Properly conducted flow cytometry and Cell Sorting experiments capture highly pure and viable cell populations, propelling the growth of the Cell Sorting Market. Thus, the wide application of flow cytometry is driving the growth of this segment.
As a result, the increasing use of flow cytometry in stem cell research and the number of stem cell clinical trials are driving this segment's growth.
North America is Expected to Witness a Significant Growth Over the Forecast Period.
North America consists of three countries: the United States, Canada, and Mexico. The region is expected to witness significant growth over the forecast period owing to rising research, rising leishmania and HIV cases, and the presence of key Flow Cytometry Companies in the region.
Mexico is seeing a rise in the number of people with leishmaniasis, and the role of flow cytometry in determining a patient's prognosis has become more important since the invention of tests to find disease and measure drug resistance. For example, a December 2022 article in the journal Tropical Medicine and Infectious Disease discussed how the number of cases of leishmaniasis has been rising over the past five years. Because there are more and more people with leishmaniasis, demand for flow cytometry to figure out prognosis is likely to rise in the coming years, boosting the Clinical Flow Cytometry Market.
The growth of the studied market is also being supported by the high number of HIV cases in Canada. For instance, in July 2022, the Government of Canada reported that an estimated 62,790 people were living with HIV in Canada during 2020-2021. Thus, a high number of HIV cases may increase the demand for frequent disease diagnosis, boosting the Flow Cytometry Analyser Market in the country and thereby driving the growth of the studied market.
The market is also growing because of increasing research and development projects. In a 2021 update from the University of North Dakota, the UND Center of Biomedical Research Excellence (CoBRE) in Host-Pathogen Interactions (HPI) stated that funding from the National Institutes of Health (NIH) will continue through Phase 2 of the project. The USD 10.7 million renewal is provided so that researchers can learn more about how the body reacts to viral, bacterial, and parasitic infections that cause both short-term and long-term inflammatory disorders. The Center will also help the School of Medicine and Health Sciences (SMHS) and UND conduct more innovative research by supporting three Phase 1 core facilities, such as flow cytometry. Such developments are anticipated to contribute to the growth of the Flow Cytometry System Market in the United States.
Also, the growth of the studied market in the region is aided by the release of new products. For example, Thermo Fisher Scientific released the Invitrogen Attune CytPix Flow Cytometer in June 2021. It is an imaging-enhanced flow cytometer contributing to the Imaging Cytometer Market that uses a high-speed camera and acoustic focusing flow cytometry technology. The Attune CytPix allows users to collect high-performance fluorescent flow cytometry data from cells while also taking high-resolution brightfield images. This lets them match images with their flow cytometry data to better understand the shape and quality of the cells.
Thus, due to the rising leishmania and HIV cases, increasing research and development, and new product launches, the market is expected to witness significant growth in the region over the forecast period.
